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Abstract 
Rationale: Accurate delineation of the intraprostatic gross tumour volume (GTV) is a 
prerequisite for individualized diagnostic and therapeutic approaches in patients with primary 
prostate cancer (PCa). Several studies showed that prostate-specific membrane antigen 
positron emission tomography (PSMA-PET) may outperform magnetic resonance imaging in 
GTV detection. However, visual GTV delineation is underlying interobserver heterogeneity 
and is time consuming. The aim of this study was to train and to validate the performance of 
a convolutional neural network (CNN) for automated segmentation of intraprostatic tumour 
(GTV-CNN) in PSMA-PET images. 
Material and Methods: The CNN (3D U-Net architecture) was trained on [68Ga]PSMA-PET 
images of 152 patients from two different institutions (Freiburg and Nanjing) and the training 
labels were generated manually using a validated contouring technique. The CNN was 
tested on two independent internal (cohort 1: [68Ga]PSMA-PET, n=18 and cohort 2: 
[18F]PSMA-PET, n=19) and one external (Hannover, cohort 3: [68Ga]PSMA-PET, n=20) test-
datasets. Accordance between manual contours and GTV-CNN was assessed with Dice-
Sørensen coefficient (DSC) and two distance based metrics. Additionally, sensitivity and 
specificity were calculated for the two internal test-datasets by using co-registered whole-
mount histology as reference material. 
Results: Median DSCs for cohorts 1-3 were 0.84 (range: 0.32-0.95), 0.81 (range: 0.28-0.93) 
and 0.83 (range: 0.32-0.93), respectively. The good DSC results were supported by distance 
based metrics. Sensitivities and specificities for GTV-CNN were comparable with manual 
expert contours: 0.98 and 0.76 (cohort 1) and 1 and 0.57 (cohort 2), respectively. 
Computation time was around 6 seconds for a standard dataset (288x288x426 voxels). 
Conclusion: The application of a CNN for automated contouring of intraprostatic GTV in 
[68Ga] and [18F]PSMA PET images resulted in a high concordance with expert contours and 
in high sensitivities and specificities in comparison with histology reference. After further 
validation, this robust, accurate and fast technique may be implemented for individualized 
diagnostic and therapeutic concepts in patients with primary PCa. The trained model and the 
study’s source code are available in an open source repository. 
Keywords: PSMA-PET, Convolutional neuronal networks, Segmentation, Prostate cancer, 
Histopathology 
 
 
 
 
 
 
 
 
  
Introduction 
Prostate cancer (PCa) is the most common tumour entity for men in North America and 
Europe in 2019 (1). In patients with newly diagnosed PCa, accurate contouring of the 
intraprostatic gross tumour volume (GTV) is mandatory for successful fusion-biopsy 
guidance (2). Additionally, focal therapy approaches such as focal dose escalation in 
radiotherapy, high intensity focused ultrasound or irreversible electroporation (3)  rely on an 
accurate definition of the intraprostatic GTV. 
Prostate-specific membrane antigen positron emission tomography (PSMA-PET) has 
recently been established for initial staging in primary PCa patients by providing an excellent 
diagnostic accuracy in detection of lymph node and bone metastases (1)). It is also 
increasingly used for intraprostatic staging in these patients in order to improve tumour lesion 
detection (4-7), focal therapy guidance (8) and non-invasive PCa characterization (9) 
compared to magnetic resonance imaging (MRI) as the current standard of care. Most of the 
studies evaluated [68Ga]PSMA-11 as radiopharmaceutical. However, [18F]PSMA-1007 is 
increasingly used for PMSA-PET imaging and Kuten et al. reported that [18F]PSMA-1007 
may detect additional low-grade lesions in direct comparison with [68Ga]PSMA-11 (10).  In a 
recent work by our group manual and semi-automatic contouring approaches for [68Ga]-
PSMA-PET images were validated based on co-registered histopathology reference material  
(11). Although good results (sensitivity and specificity > 80%) were obtained for most of the 
contouring approaches, some methodologies showed a rather poor performance (sensitivity 
and specificity < 70%). This is in line with a dice-index (DSC) varying between 0.56-0.8 for 
the manual contours, which indicates that PSMA-PET based GTV-definition underlies a 
substantial interobserver variability. Actually, no validated contouring technique for [18F]-
PSMA-PET was proposed so far. 
The implementation of an automatic segmentation algorithm may enhance intraprostatic 
GTV-delineation in PSMA-PET images by extending the two main limits of conventional 
contouring approaches: interobserver heterogeneity and expenditure of time. With the rise of 
deep learning in the recent years convolutional neural networks (CNNs) based algorithms 
achieved remarkable results handling this task. In a work by Zhao et al. the pelvic PCa 
tumour burden in [68Ga]-PSMA-PET images was accurately detected by a CNN with 99% 
precision (12). Although several works already reported the excellent performance of CNNs 
in prostatic gland delineation on CT images (13) or PCa diagnosis based on multiparametric 
magnetic resonance images (14) the usage of CNNs for intraprostatic GTV contouring in 
PSMA-PET was not examined yet.  
The aim of this work is to examine the capabilities of CNNs for intraprostatic GTV contouring 
in [68Ga]- and [18F]-PSMA-PET images. Models were trained on two independent cohorts 
(Freiburg and Nanjing) with [68Ga]-PSMA-PET images using a validated technique for 
manual intraprostatic GTV contouring (11). The network was thoroughly evaluated on 
external (Hannover, 1 cohort: [68Ga]-PSMA-PET/CT scans) and internal (2 cohorts from 
Freiburg: [68Ga] or [18F]PSMA-PET/CT scans) cohorts as well as on co-registered whole-
mount histopathology reference.  
 Methods and Materials 
Patients 
The current analysis evaluated data from 209 patients with primary PCa from three different 
centres (centre 1: Freiburg, centre 2: Nanjing, centre 3: Hannover). Inclusion criteria were 
histologically proven primary adenocarcinoma of the prostate and no local or systemic 
treatment prior to PSMA-PET imaging. The local ethics committees from all three centres 
approved the study and written consent was waived due to the retrospective character of the 
study. Please see table 1 for a detailed description of the patients` characteristics. 
The training cohort consisted in total of 152 (107 centre1 and 45 centre 2) patients with 
68Ga]PSMA-11 PET/CT scans. The CNN was tested on 3 independent test datasets: 18 
patients from centre 1 ([68Ga]PSMA-11, cohort 1), 19 patients from centre 1 ([18F]PSMA-
1007, cohort 2) and 20 patients from centre 3 ([68Ga]PSMA-11, cohort 3) Further, the CNN 
contours were assessed by coregistered histopathology information in both internal validation 
cohorts. 
PET/CT Imaging  
PET/CT Imaging: Centre 1 
A detailed description of the radiolabelling protocol of [68Ga]-PSMA-11 and [18F]PSMA-1007 
from centre 1 can be found in Zamboglou et al (15) and in Cardinale et al. (16), respectively. 
One hour ([68Ga]-PSMA-11) and two hours ([18F]PSMA-1007) after intravenous tracer 
injection, all patients underwent whole body PET scan. Protocols were acquired on three 
different cross-calibrated Philips scanners: GEMINI TF TOF 64, GEMINI TF 16 Big Bore and 
Vereos. All scanners fulfilled the requirements indicated in the European Association of 
Nuclear Medicine (EANM) imaging guidelines and obtained EANM Research Ltd. (EARL) 
accreditation during acquisition (17, 18). All scanners resulted in a PET image with a voxel 
size of 2 x 2 x 2 mm3. Images were normalized to decay corrected injected activity per kg 
body weight (standardized uptake values, SUV in [g/ml]). As a result of the EARL 
accreditation process, comparable SUV parameters were derived.  
PET/CT Imaging: Centre 2 
[68Ga]PSMA-11 was synthesized using an ITG semiautomated module as described 
previously (19). One hour before scanning, all patients were intravenously injected with 
[68Ga]PSMA-11. PET/CT was performed on an uMI 780 PET/CT scanner (United Imaging 
Healthcare). A CT scan (130 keV, 80 mAs) and a static emission scan, corrected for dead 
time, scatter, and decay, were acquired from the vertex to the proximal legs. The scanner 
resulted in a PET image with a voxel size of 2.3 x 2.3 x 2.7 mm. A resampling step was 
performed to obtain a PET image voxel size of 2 x 2 x 2 mm (tri-linear interpolation in 
plastimatch v1.8.0) before training of the CNN. Expert contours of intraprostatic GTV and 
prostate contours were resampled with nearest neighbor interpolation (plastimatch v1.8.0). 
PET/CT Imaging: Centre 3 
[68Ga]-PSMA-11 was synthesized as described previously (20). All studies were acquired 
using a Biograph mCT 128 Flow scanner (Siemens, Knoxville, USA) one hour after tracer 
injection, as described previously (20).  
PET images had a voxel size of 4.1 x 4.1 x 5 mm. Validation was performed with the original 
data and with three different resampling methods to obtain a PET image voxel size of 2 x 2 x 
2 mm. 
Histopathology and PET/CT image coregistration 
For 29 patients from centre 1 (cohort 1: n=18 and cohort 2: n=11) the three-dimensional (3D) 
distribution of the intraprostatic GTV was obtained by histology information from 
prostatectomy specimen using an in-house coregistration protocol, as previously described 
(13, 21). After formalin fixation, the resected specimen underwent an ex-vivo CT scan using 
a customized localizer and whole-mount step sections were cut every 4 mm using an in-
house cutting device. Staining with hematoxylin and eosin was performed via routine 
protocols and PCa tissue in histology was delineated by pathologists. Histology slices were 
registered on ex-vivo CT images and PCa contours were transferred onto the CT images. 
The contours were interpolated to create a model of the 3D distribution of PCa in histology 
(GTV-Histo). Ex-vivo CT (including GTV-Histo contours) was registered on in-vivo CT (from 
PSMA-PET/CT scans) by manual coregistration including elastic deformations. The final 
alignment of in-vivo CT and PET scans was based on the hardware coregistration of the 
hybrid PET/CT scanners.  
Contouring of PSMA PET/CT images 
For all patients, GTVs based on [
68Ga]PSMA-PET images were manually delineated by two 
experienced readers (GTV-Exp) in consensus using 3D Slicer (Version 4.10.0) as proposed 
previously by our group (11). Any monofocal or multifocal uptake greater than adjacent 
background uptake in more than one slice within the CT-defined prostate gland was defined 
as presence of PCa. GTVs were delineated manually in every single slice using inverted grey 
color scale for display, thresholded with a SUVmin and max of 0 and 5, respectively. GTV-
PET on [
18F]PSMA-PET images was obtained by using the same procedure. Additionally, 
threshold based contouring with 30% of intraprostatic SUVmax was applied (GTV-30%) (4) 
for the patients with histopathology reference in test cohorts 1 and 2. 
The contour of the prostatic gland on corresponding CT images was delineated by an 
experienced radiation oncologist for all patients. 
Preprocessing 
The data were converted from the digital imaging and communications in medicine (DICOM) 
standard to the nearly raw raster data (NRRD) format, cropped to a size of 64x64x64 voxels 
in all dimensions and normalized with 𝑥𝑖′ =
𝑥𝑖−𝑥
𝜎
, where 𝑥𝑖 is the PET data of patient 𝑖, 𝑥 the 
arithmetic mean and 𝜎 the standard deviation within all cropped datasets in the 
corresponding training cohort.  
As it is not possible to accurately differentiate between prostatic tissue and surrounding 
tissues solely based on PET and since differences in the contours due to interobserver 
variability could mislead the network, only delineations inside the prostatic gland contour 
were used for computations.  
To investigate the impact of a voxel size different from the training voxel size and the usage 
of different interpolation algorithms we used the PETs from centre 3 in four different ways. 
First, the original data was fed to our network. In a second setting, the PETs from centre 3 
were resampled to a resolution of 2 x 2 x 2 mm with three different methods (SimpleITK 
v1.2.4):  B-spline interpolation order 3, tri-linear interpolation and Gaussian interpolation. 
Prostate contours and ground truth GTVs were resampled with nearest neighbor 
interpolation.  
Convolutional neural network 
According to the majority of successful end-to-end segmentation methods for volumetric 
medical image segmentation tasks (17, 22), the current work was based on a 3D variant of 
the U-Net architecture. The chosen network consists of 3 down sampling steps with max-
pooling, 3 upsampling steps with transposed convolution layers (kernel size: 2x2x2, stride: 2, 
padding: 1) and skip connections by concatenation. The 18 convolution blocks consist of 3 x 
3 x 3 convolutions with stride and padding of 1, followed by Batch Normalization (BN) and 
ReLU activation, except for the last convolution where 1 x 1 x 1 convolution without padding, 
BN and Sigmoid activation function were used. An argmax function over the final feature map 
formed the predicted GTV. An illustration of the network can be found in Figure 1. The 
network weights were optimized using ADAM (23). 
Convolutional neural network: Training 
The 152 patients of the training cohort were further split into training and evaluation cohort of 
142 and 10 patients, respectively. The evaluation cohort was used for optimizing the CNN’s 
hyper-parameters during the training process. As input the CNN received a concatenation of 
the patients’ PET and prostate contour. Hyper-parameter optimization was done using a grid 
search. The best performing setting was achieved with Adam 𝛽1 = 0.9 ∧ 𝛽2 = 0.999, a learning 
rate of 0.0001 and training for 1019 epochs (an epoch means iterating over all training 
samples once) with a dice loss: 𝑑𝑖𝑐𝑒𝑙𝑜𝑠𝑠(𝑋, 𝑌) = 1 −
2∑ 𝑤𝑙
|𝐿|
𝑙=1 ∑ 𝑦𝑙𝑛𝑛 𝑥𝑙𝑛
∑ 𝑤𝑙
|𝐿|
𝑙=1
∑ 𝑦𝑙𝑛𝑛 +𝑥𝑙𝑛
 for |𝐿| number of labels, 
N image elements 𝑥0,...,𝑁 ∈ 𝑋, 𝑦0,...,𝑁 ∈ 𝑌and without weighting the label classes 𝑤𝑙 = 1. Data 
augmentation was performed during grid search but achieved worse results than the above 
mentioned setting without augmentation. Consequently no data augmentation was used for 
further analyses. 
In Figure 2 a visualization of the training and evaluation curves can be seen. As both loss 
curves decrease almost simultaneously and the distance between them stays constant we 
assume that the network generalizes well and overfitting is unlikely.  
Convolutional neural network: Evaluation 
Due to the mentioned reasons in 3.5 only the output of the CNN inside the contour of the 
prostatic gland was considered.  
We assessed the agreement between GTV-Exp and GTV-CNN at voxel level using the Dice-
Sørensen coefficient (DSC). When applied at voxel level, this index is identical to the kappa 
index (8). As volume-based metrics (like DSC) show a lower sensitivity to errors where 
outlines deviate and the volume of the erroneous region is small compared to the total 
volume, we considered also distance-based metrics like the Hausdorff distance (HD) and the 
average symmetric surface distance (ASSD). Additionally, we calculated the sensitivity and 
specificity for all GTVs based on the histology standard of reference data as performed 
previously by our group (13). The prostate in each CT slice (from PSMA-PET/CT scans) was 
divided into four equal segments and the analysis was performed visually using the GTVs 
obtained. A median of 52 segments (range: 20-64) per patient were analysed. 
In a last experiment we were interested whether there are clinical factors that might impact 
the CNN performance by influencing the SUV distribution (PSA values and Gleason score) or 
by neighborhood to bladder signal (localization). Patients from cohorts 1 and 3 (resampling: 
tri-linear interpolation) were pooled and a logistic regression was performed to assess the 
impact of initial PSA values, Gleason score, cT stage and tumour localization on the 
concordance of GTV-CNN and GTV-Exp in terms of DSC. The median DSC of pooled 
cohorts was used as cut-off point. 
Convolutional neural network: Implementation 
The network was implemented with pytorch 1.3.1 and torchvision 0.4.2. Gradients for 
backpropagation were calculated with the pytorch autograd library which keeps track of all 
operations and builds a computational tree. 
For further details please see the provided code on GitLab: 
(https://gitlab.com/dejankostyszyn/prostate-gtv-segmentation) 
Computations were done on a PC with a Intel ® Xeon ® Silver 4114 CPU @ 2.20GHz, 64 
GB memory and a NVIDIA ® Quadro ® P5000, 16GB, 4DP, DL-DVI-D GPU.  
Statistical analysis 
The statistical analysis was performed with MedPy’s package ‘Metric Measures’ v0.4.0 and 
GraphPad Prism v8.1.0 (GraphPad Software). Pairwise comparisons (DSC, ASSD, HD, 
sensitivity and specificity) were performed with the Wilcoxon matched-pairs signed rank or 
Friedman test. Non-pairwise testing was performed with Mann-Whitney test (initial PSA) and 
Chi-square test (cT stage and Gleason score). The tests were chosen due to non-normal 
distribution (Shapiro-Wilk test) of the data. Furthermore, a binary logistic regression analysis 
with pooled cohorts 1 and 3 was performed to assess the impact of basic clinical parameter 
on DSC between GTV-Exp and GTV-CNN. The confidence alpha was set to 5% for all 
analyses. 
 
Results 
Test results [68Ga]-PSMA-11 PET  
GTV-CNN was compared to GTV-Exp on internal and external testing cohorts. On the 
internal datasets (cohort 1) the network yielded median DSC, median HD and median ASSD 
of 0.84 (range: 0.32-0.94), 4mm (range: 1.41-10) and 0.61mm (range: 0.24-1.46), 
respectively (Table 2). CNN performance was further assessed by correlation with histology 
reference (Figure 3) and median sensitivity and specificity of 0.98 (range: 0.38-1) and 0.76 
(range: 0.13-1) were observed.  
The achieved sensitivity and specificity was comparable to GTV-Exp and GTV-30% (Figure 
4). The median absolute volumes of the GTVs were: 10.7ml (range: 0.7-101) for GTV-CNN, 
11.8ml (range: 0.8-75) for GTV-Exp, 8ml (range: 2.2-41) for GTV-30% and 10.4ml (range: 
1.6-103) for PCa volume in histology reference. No significant differences between absolute 
volume of GTV-CNN and the three other volumes were observed. The GTV-CNN 
encompassed in median 26.6% of the prostatic gland. 
Patients in the external test cohort (cohort 3) had statistically significant differences between 
Gleason scores but not between initial PSA values and cT stage (Table 1). Comparison 
between GTV-CNN and GTV-Exp was performed firstly on non-resampled and secondly on 
resampled PET images (Table 2). Friedman test revealed statistically significant (p<0.01) 
differences in DSC, HD and ASSD among the different pre-processing procedures and no 
pre-processing. Post-hoc analyses revealed no statistically significant differences between 
the three interpolation approaches (p>0.05). Best results were achieved by using tri-linear 
interpolation with median DSC 0.83 (range: 0.32-0.93), median HD 4.12mm (range: 2.01-
22.36) and median ASSD 0.46mm (range: 0.28-1.61), respectively. 
In logistic regression analysis with pooled cohorts 1 and 3 no clinical parameter had a 
statistically significant impact on DSC between GTV-Exp and GTV-CNN (supplementary 
Table 1). 
Test results [18F]-PSMA-1007 PET  
The trained CNN was also tested on 19 patients from cohort 2. Considering GTV-PET for 
comparison median DSC, median HD and median ASSD were 0.81 (range: 0.28-0.93), 5mm 
(range: 1.41-8.49) and 0.51mm (range: 0.26-1.57), respectively (Table 2). Considering 
histology as standard of reference calculated sensitivity and specificity were 1 (range: 0.86-1) 
and 0.57 (range: 0.12-1). GTV-CNN had a significant higher sensitivity than GTV-30% 
(p=0.01) but not than GTV-Exp (p=0.48).  No statistically significant differences in specificity 
(p>0.05) were observed between GTV-CNN and the other two GTVs. In the 11 patients with 
co-registered histology information median tumour volume was 3.5ml (range: 0.3-24.4) for 
histology reference, 8.5ml (range: 1.9-38) for GTV-CNN, 3 ml (range: 0.6-21.5) for GTV-30% 
and 7.2ml (range: 1.2-36) for GTV-Exp. GTV-CNN was statistically significant larger (p>0.05) 
than all three other volumes (p<0.05) and encompassed in median 32% (range: 9-86) of the 
prostatic gland. 
Computation time 
For internal validation cohorts ([18F] and [68Ga]PSMA) the segmentation of the intraprostatic 
tumour of one patient took in median 6 and 6.28 seconds, respectively, for the complete 
process, including loading the PET and prostate contour from hard drive and storing the 
predicted GTV onto hard drive. This process took 23.3-27.8 seconds (in dependency of the 
used interpolation technique) for external validation cohort, because the data was scaled to 
443% of the internal cohort’s data volume after resampling. A single forward pass through 
the CNN took less than a second (approx. 3 µs) for all cohorts. For further information please 
see Table 2. 
Discussion 
Implementation of automatic GTV-segmentation approaches based on CNN algorithms have 
already been introduced for several other tumour sites like gliomas (18, 24) or lung cancer 
(21). Although several studies achieved promising results by using CNNs for auto 
segmentation of the prostatic gland in mpMRI or CT there is limited evidence on the 
segmentation of the intraprostatic GTV(25). To the best of our knowledge our study is the 
first study analyzing CNNs for intraprostatic GTV delineation based on PET images. We 
chose PSMA-PET images since several studies reported that PSMA-PET outperforms the 
current standard of care (multiparametric magnetic resonance imaging) for intraprostatic 
tumour detection (4-7). Consequently, the use of PSMA-PET imaging for initial staging (26) 
and intraprostatic GTV detection and contouring (27, 28) has been established in the last 
years and several studies suggested its implementation for treatment individualization in 
primary PCa patients (29, 30). However, all previous studies used manually or semi-
automatically created contours for intraprostatic GTV contouring which may be impeded by 
low sensitivity/specificity and interobserver heterogeneity (11). It should be also considered, 
that manual contouring of GTV in the prostate is time consuming and may bind human 
resources. Obviously, a fast, robust and accurate workflow for intraprostatic GTV contouring 
is a prerequisite for a broader deployment of PSMA PET-based procedures targeting the 
prostatic gland. In this work we were able to show for the first time that CNN have the ability 
to delineate the intraprostatic GTV on PSMA-PET with accuracy comparable to human 
experts within seconds. Thus, it is likely that PSMA-PET/CT imaging in combination with 
CNN-based intra- and extraprostatic (12) tumour detection and segmentation may provide a 
“one-stop shop” tool for tailoring individualized treatment approaches for primary PCa 
patients.  
In our study the CNN was trained with [68Ga]-PSMA-PET data of 152 patients from two 
different institutions using a validated approach for GTV delineation. The CNN performance 
for [68Ga]PSMA-PET images was tested on two independent datasets as well as using 
histology reference material. In comparison with manually delineated expert contours very 
good DSC values (>0.8) were observed for both validation datasets. Bravaccini et al. 
reported that the PSMA expression correlates with the Gleason score (31) and the two test 
cohorts had statistically significant differences in Gleason score in biopsy probes. The good 
agreement between GTV-CNN and GTV-Exp in both test cohorts suggests that the CNN 
performance is independent of the Gleason score. In rare cases a high HD was observed 
despite a high DSC. This was the case when the main parts of CNN and expert GTVs 
overlapped, but small regions with a high distance to the main tumour, were diagnosed as 
malignant by the CNN, but not by the human experts. For example, in two patients of the 
internal validation cohort ([68Ga]PSMA-PET) the CNN detected small (<0.5 mm in histology 
reference material) lesions which were missed by visual PET interpretation. This explains the 
slightly higher sensitivity of the CNN cohort 1 although the absolute GTV volumes were 
comparable between experts and CNN. Since HD is sensitive to outliers, we used ASSD as 
additional metric. In our tests all segmentations with regions to reassess had an ASSD > 1, 
while results < 1 could be considered as good segmentations. Hence, we recommend 
considering not just DSC, but also HD and ASSD to evaluate CNN contouring accuracies.  In 
comparison with histology reference GTV-CNN achieved excellent sensitivity and good 
specificity in [68Ga]PSMA-PET images, which was comparable to manually delineated expert 
contours and threshold based contours using 30% of intraprostatic SUVmax. Additionally, the 
absolute volume of GTV-CNN was very similar to the histology reference volume suggesting 
a good coverage of the intraprostatic tumour mass by the CNN. Since GTV-CNN 
encompassed in median 26.6% of the prostatic gland, it is very likely that focal therapy 
approaches guided by CNN are feasible in most of the patients.  
[68Ga]PSMA-PET images of the external validation cohort were tested with and without 
previous resampling. Statistically significant differences were observed with better results for 
the resampled datasets. Hence, when using different datasets from different institutions a 
resampling of the images to the same voxel size of the training data set should be performed 
in order to enhance the CNN performance.  In direct comparison between three different 
interpolations for resampling no statistically significant differences were observed. However, 
considering a decent better performance for tri-linear interpolation this method should be 
considered for future studies. Consequently, the automatic GTV delineation in [68Ga]PSMA-
PET images with CNNs is a promising tool for intraprostatic tumour segmentation offering a 
robust, accurate and fast alternative to visual PET image interpretation. However, in some 
patients discrepant results between CNN and manual contours were observed. Moreover, 
PET signal from the adjacent bladder may mislead the CNN in contouring of PCa lesions in 
the prostatic base. However, no clinical parameters like Gleason Score or tumor localization 
had an impact on the concordance between GTV-Exp and GTV-CNN in regression analysis. 
Thus, we strongly advise to perform a visual control of the CNN segmentations in every 
patient.  
Interestingly, the CNN provided also a high concordance with expert contours (DSC>0.8) in 
contouring of [18F]PSMA-PET images. This result should be interpreted with caution since no 
validated approach for contouring was applied. However, considering histology as standard 
of reference an excellent sensitivity was observed which was comparable to manual contours 
and better than threshold based contours. Taking into account the differences in physical 
properties and in bio distribution between both tracers this result is surprising. However, the 
specificity of GTV-CNN was low (<0.65) which is mainly explained by a significant 
overestimation of the tumour volume. Thus, the CNN may also be used for GTV contouring 
in [18F]PSMA-PET images, especially in situations when a good coverage of the intraprostatic 
GTV is demanded and a high coverage of non-tumour bearing prostatic tissue is negligible. 
Surely, further studies implementing [18F]PSMA-PET images and validated expert contours 
for training and testing are necessary to confirm this observation.  
A limitation of our study is the relatively low number of patients used for testing the CNN 
(n=57) which is explainable by the elaborate co-registration protocol used in our study for two 
independent cohorts. We assume that the observed results are robust since we used 
different, independent datasets for evaluation and received comparable results for all of 
them. Another point that supports the robustness is that we did not notice any overfitting in 
the training process. Considering the high value of the two independent datasets used for 
testing the CNN, no additional approaches for validation were performed (e.g. k-fold cross-
validation). A different potential limitation of our study is the uncertainty in correlation of 
PSMA PET images and histopathology slices (e.g. non-linear shrinkage of the prostate after 
prostatectomy). Thus, it could not be excluded that moderate or low coverage of PCa in 
histology by the PET-derived GTVs is a consequence of mismatch in coregistration or 
incomplete histopathological coverage instead of poor tracer or CNN performance. 
Additionally, Gibson et al. proved that pathologists tend to underestimate the true extent of 
disease (32). However, as the calculation of sensitivities and specificities was not performed 
on a voxel-level but on a less stringent slice by slice level, we consider the potential resulting 
bias negligible. Another issue is that, mainly PCa patients with intermediate- or high-risk PCa 
are referred for PSMA-PET imaging. As a result, the findings from our study are only 
representative for intermediate- and high-risk PCa patients. Consequently, further studies 
need to proof our results for low-risk PCa patients. Very recently a new CNN architecture 
(modified U-NET) was introduced (33) in order to overcome potential limitations in 
segmentation of small lesions. Future studies should assess whether implementation of this 
new approach further increases the results.  
In conclusion, our study presents a CNN for automated contouring of intraprostatic GTV in 
[68Ga] and [18F]PSMA-PET images resulting in a high concordance with expert contours and 
in high sensitivities and specificities in comparison with histology reference. Likewise, CNN-
based GTV delineation is a promising and fast alternative to visual PET image interpretation 
offering a high accuracy. The link to the code and trained model of the CNN can be found in 
chapter 3.5.4. and may be used for individualized treatment (e.g. focal therapy) and 
diagnostic (e.g. radiomic feature extraction or fusion-biopsy) concepts in patients with 
primary PCa on two ways: (1) before visual image interpretation the CNN may provide a 
proposal and (2) after visual image interpretation the CNN may be used for quality 
assurance. However, we strongly emphasize that a visual control of the CNN contours by 
experienced experts is still obligatory in both approaches. Additionally, we will further train 
and validate the network and will offer updated versions of the underlying code. 
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Tables 
Table 1. Patient characteristics  
 
 Centre 1 Centre 2 Centre 3 
Median Age in years (range) 70 (48-88) 69 (55-84) 71.5 (59-84) 
Median PSA in ng/ml (range) 13.1 (4.4-218) 13.3 (4.04-110) 
12.8 (1.91-
108.10) 
Gleason Score, n and %     
 6 5 (3.4) 4 (8.9) 0 
7a 44 (30.1) 12 (26.7) 3 (15) 
7b 43 (29.9) 12 (26.7) 3 (15) 
8 24 (16.7) 10 (22.2) 6 (30) 
9 19 (13.2) 7 (15.5) 8 (40) 
unknown 9 (6.3) 0 0 
cT stage, n and %     
 2 89 (61.8) 14 (30.8) 6 (30) 
3 55 (38.2) 31 (69.2) 14 (70) 
n patients with [68Ga]PSMA-PET/CT, total 125   20 
       n patients training cohort 107 45 
        n patients validation cohort 18   
        n patients with histology reference 18   
 n patients with [18F]PSMA-PET/CT, total 19   
        n patients validation cohort 19   
        n patients with histology reference 11 
   
Differences in the two test cohorts ([68Ga]-PSMA-PET images) from centre 1 and 3 were 
analyzed. No differences in initial PSA values and cT stage were observed (p>0.05). 
However, patients from centre 3 had statistically significant (p=0.035) higher Gleason scores 
than patients from centre 1. 
Table 2.  
  DSC HD (mm) ASSD (mm) 
Computation time 
(sec) 
  Median Min Max Median Min Max Median Min Max Median Min Max 
Internal validation [68Ga]PSMA-11 0.84 0.32 0.95 4.03 1.42 10.0 0.61 0.28 1.97 6.28 5.47 7.66 
Internal validation [18F]PSMA-
1007 0.81 0.28 0.93 5.0 1.41 8.49 0.5 0.26 1.82 6.00 3.53 9.2 
External validation [68Ga]PSMA-
11 
  
    
 
    
 
  
  
  
No resampling 0.78 0.11 0.89 12.57 1.43 32.9 0.62 0.27 4.03 1.93 0.27 2.02 
B-spline interpolation 0.82 0.39 0.92 5.83 2.45 22.36 0.55 0.32 2.1 27.79 10.54 30.91 
Tri-linear interpolation 0.83 0.32 0.93 4.12 2.01 22.36 0.46 0.28 1.61 23.32 10.55 26.37 
Gaussian interpolation 0.81 0.04 0.94 7.35 2.24 20.05 0.55 0.19 3.72 25.13 10.49 28.3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figures 
Figure 1. Illustration of the network. Numbers below layers represent the number of 
channels, numbers to the right of a layer represent the shape of the data cube after 
executing the layer’s operations.  
  
 
 
 
 
 
 
 
Figure 2. Visualization of the training and evaluation curves. Training and evaluation results 
as dice loss and Dice-Sørensen coefficient (DSC) in A as well as Hausdorff distance (HD) 
and average symmetric surface distance (ASSD) in B. 
  
A B 
 Figure 3. Histology reference and [68Ga]-PSMA-11 PET/CT scan from a representative 
patient of cohort 1 are shown. A: Hematoxilin and eosin whole-mount prostate slide with 
marked PCa lesion in blue.  B: Axial slide of CT-scan. Each CT slide was divided into 4 
segments to calculate sensitivity and specificityfor each patient. C: Axial slide PET-scan 
(image scaling: SUVmin-max=0-5). D: Zoom of the PSMA-PET-positive Lesion. Blue contour: 
Prostate. Green contour: histology reference. Yellow contour: GTV-Exp. Black contour: GTV-
CNN. 
 Figure 4. Comparison of specificity and sensitivity between GTV-CNN, GTV-Exp and GTV-30% based 
on histology reference in cohort 1 and 2. Box plots including median values, interquartile range and 
sensitivity/specificity for each individual patient are presented. Pairwise comparison was performed 
with Wilcoxon signed-rank test. Abbrevations: n.s.: not significant, *: p=0.05-0.01, CNN: convolutional 
neural network. 
Funding  
 
This study was funded from the ERA PerMed call 2018 (BMBF) 
 
 
 
 
 
 
